Back

Albuminuria is associated with worse outcomes in non-diabetics hospitalized with acute heart failure

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Kidney disease in patients with heart failure Biomarkers ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yoshimitsu Takaoka

University of California San Diego, San Diego (United States of America)

5 More presentations in this session

Presentation thumbnail
Clinical features and treatment of patients with heart failure and advanced chronic kidney disease
Doctor M. Anguita Gamez (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
The prognostic implication of urine dip stick proteinuria in patients with acute heart failure
Doctor H. Chang (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Worsening renal function at 1 year after acute heart failure
Doctor S. Takeuchi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
impact of advanced chronic kidney disease stages on heart failure mortality: a nationwide analysis using CDC WONDER
Doctor Q. Abdul (Dartford, GB)
Abstract Slides Video
Presentation thumbnail
Cardio-renal-metabolic multimorbidity and myocardial function in acute STEMI: decoding the triple threat with advanced echocardiography
Doctor J. Vratonjic (Belgrade, RS)
Abstract Slides Video

Access the full session

Session thumbnail
Kidney disease in patients with heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiovascular and renal outcomes related to urinary albumin to creatinine ratio in patients with heart failure and reduced ejection fraction: A pooled analysis of ATMOSPHERE and PARADIGM-HF
thumbnail
Congress Presentation
Albuminuria and acute heart failure. Prognostic implications and short-term mortality.
thumbnail
Congress Presentation
Early changes in albuminuria and their interaction with eplerenone treatment in patients hospitalized for acute heart failure: findings from the EARLIER trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources